Stay updated with breaking news from Pharma Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of N4 Pharma Plc (LON:N4P – Get Free Report) hit a new 52-week low on Monday . The company traded as low as GBX 0.70 ($0.01) and last traded at GBX 0.70 ($0.01), with a volume of 177605 shares trading hands. The stock had previously closed at GBX 0.78 ($0.01). N4 Pharma Stock Performance […]
N4 Pharma Plc provides an update on its in vitro siRNA research work, showcasing the versatility of their Nuvec® delivery system for cancer treatments.
N4 Pharma Plc announces the granting of a patent for its Nuvec® delivery system in India, adding to its global portfolio of granted patents.
N4 Pharma's subsidiary, Nanogenics, has signed a contract to prepare its ECP105 product for pre-clinical studies in Glaucoma treatment.
/PRNewswire/ -- The human microbiome therapeutics market is expected to grow by USD 732.95 million from 2022 to 2027. In addition, the momentum of the market...